Evaluation of alpaca tracheal explants as an ex vivo model for the study of Middle East respiratory syndrome coronavirus (MERS-CoV) infection

Vet Res. 2022 Sep 2;53(1):67. doi: 10.1186/s13567-022-01084-3.

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) poses a serious threat to public health. Here, we established an ex vivo alpaca tracheal explant (ATE) model using an air-liquid interface culture system to gain insights into MERS-CoV infection in the camelid lower respiratory tract. ATE can be infected by MERS-CoV, being 103 TCID50/mL the minimum viral dosage required to establish a productive infection. IFNs and antiviral ISGs were not induced in ATE cultures in response to MERS-CoV infection, strongly suggesting that ISGs expression observed in vivo is rather a consequence of the IFN induction occurring in the nasal mucosa of camelids.

Keywords: Air-liquid interface; MERS-CoV; alpaca; camelid; ex vivo model; tracheal explants.

MeSH terms

  • Animals
  • Antiviral Agents
  • Bronchi
  • Camelids, New World*
  • Coronavirus Infections* / veterinary
  • Middle East Respiratory Syndrome Coronavirus* / physiology

Substances

  • Antiviral Agents